These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35786627)

  • 21. New prognostic factors in uveal melanomas: potential molecular targets for therapy.
    Saraiva VS; Edelstein C; Burnier MN
    Can J Ophthalmol; 2004 Jun; 39(4):422-7. PubMed ID: 15327108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on Metastatic Uveal Melanoma: Progress and Challenges.
    Spagnolo F; Picasso V; Spano L; Tanda E; Venzano C; Queirolo P
    BioDrugs; 2016 Jun; 30(3):161-72. PubMed ID: 27000042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The "ART" of Epigenetics in Melanoma: From histone "Alterations, to Resistance and Therapies".
    Strub T; Ballotti R; Bertolotto C
    Theranostics; 2020; 10(4):1777-1797. PubMed ID: 32042336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncogenic signaling in uveal melanoma.
    Park JJ; Diefenbach RJ; Joshua AM; Kefford RF; Carlino MS; Rizos H
    Pigment Cell Melanoma Res; 2018 Nov; 31(6):661-672. PubMed ID: 29738114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastatic disease from uveal melanoma: treatment options and future prospects.
    Carvajal RD; Schwartz GK; Tezel T; Marr B; Francis JH; Nathan PD
    Br J Ophthalmol; 2017 Jan; 101(1):38-44. PubMed ID: 27574175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uveal melanoma: Towards a molecular understanding.
    Smit KN; Jager MJ; de Klein A; Kiliҫ E
    Prog Retin Eye Res; 2020 Mar; 75():100800. PubMed ID: 31563544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological characteristics and clinical management of uveal and conjunctival melanoma.
    Kaštelan S; Pavičić AD; Pašalić D; Nikuševa-Martić T; Čanović S; Kovačević P; Konjevoda S
    Oncol Res; 2024; 32(8):1265-1285. PubMed ID: 39055896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The genetics of uveal melanoma: an emerging framework for targeted therapy.
    Harbour JW
    Pigment Cell Melanoma Res; 2012 Mar; 25(2):171-81. PubMed ID: 22268848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
    Smith JH; Padnick-Silver L; Newlin A; Rhodes K; Rubinstein WS
    Ophthalmology; 2007 Apr; 114(4):774-9. PubMed ID: 17207529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic implications of the emerging molecular biology of uveal melanoma.
    Patel M; Smyth E; Chapman PB; Wolchok JD; Schwartz GK; Abramson DH; Carvajal RD
    Clin Cancer Res; 2011 Apr; 17(8):2087-100. PubMed ID: 21444680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current molecular and clinical insights into uveal melanoma (Review).
    Fallico M; Raciti G; Longo A; Reibaldi M; Bonfiglio V; Russo A; Caltabiano R; Gattuso G; Falzone L; Avitabile T
    Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysregulated GPCR Signaling and Therapeutic Options in Uveal Melanoma.
    Chua V; Lapadula D; Randolph C; Benovic JL; Wedegaertner PB; Aplin AE
    Mol Cancer Res; 2017 May; 15(5):501-506. PubMed ID: 28223438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas.
    Makohon-Moore AP; Lipson EJ; Hooper JE; Zucker A; Hong J; Bielski CM; Hayashi A; Tokheim C; Baez P; Kappagantula R; Kohutek Z; Makarov V; Riaz N; Postow MA; Chapman PB; Karchin R; Socci ND; Solit DB; Chan TA; Taylor BS; Topalian SL; Iacobuzio-Donahue CA
    Clin Cancer Res; 2021 Mar; 27(5):1516-1525. PubMed ID: 33323400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of SDHD promoter mutations in various types of melanoma.
    Scholz SL; Horn S; Murali R; Möller I; Sucker A; Sondermann W; Stiller M; Schilling B; Livingstone E; Zimmer L; Reis H; Metz CH; Zeschnigk M; Paschen A; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
    Oncotarget; 2015 Sep; 6(28):25868-82. PubMed ID: 26327518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling.
    Griewank KG; Koelsche C; van de Nes JAP; Schrimpf D; Gessi M; Möller I; Sucker A; Scolyer RA; Buckland ME; Murali R; Pietsch T; von Deimling A; Schadendorf D
    Clin Cancer Res; 2018 Sep; 24(18):4494-4504. PubMed ID: 29891723
    [No Abstract]   [Full Text] [Related]  

  • 36. Research in practice: Therapeutic targeting of oncogenic GNAQ mutations in uveal melanoma.
    Gaffal E
    J Dtsch Dermatol Ges; 2020 Nov; 18(11):1245-1248. PubMed ID: 32954611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrin expression in uveal melanoma differs from cutaneous melanoma.
    ten Berge PJ; Danen EH; van Muijen GN; Jager MJ; Ruiter DJ
    Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3635-40. PubMed ID: 8258522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic Alterations and Therapeutic Opportunities in Rare Forms of Melanoma.
    Han A; Schug ZT; Aplin AE
    Trends Cancer; 2021 Aug; 7(8):671-681. PubMed ID: 34127435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infrequent expression of the MAGE gene family in uveal melanomas.
    Mulcahy KA; Rimoldi D; Brasseur F; Rodgers S; Liénard D; Marchand M; Rennie IG; Murray AK; McIntyre CA; Platts KE; Leyvraz S; Boon T; Rees RC
    Int J Cancer; 1996 Jun; 66(6):738-42. PubMed ID: 8647642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathology and genetics of uveal melanoma.
    Griewank KG; Murali R
    Pathology; 2013 Jan; 45(1):18-27. PubMed ID: 23222249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.